Spain Perfusion Systems Market Size & Outlook, 2023-2030
The perfusion systems market in Spain is expected to reach a projected revenue of US$ 35.9 million by 2030. A compound annual growth rate of 2.6% is expected of Spain perfusion systems market from 2024 to 2030.
The Spain perfusion systems market generated a revenue of USD 30.1 million in 2023 and is expected to reach USD 35.9 million by 2030.
The Spain market is expected to grow at a CAGR of 2.6% from 2024 to 2030.
In terms of segment, cardiopulmonary perfusion system was the largest revenue generating application in 2023.
Cardiopulmonary Perfusion System is the most lucrative application segment registering the fastest growth during the forecast period.
Perfusion systems market data book summary
Market revenue in 2023
USD 30.1 million
Market revenue in 2030
USD 35.9 million
Growth rate
2.6% (CAGR from 2023 to 2030)
Largest segment
Cardiopulmonary perfusion system
Fastest growing segment
Cardiopulmonary Perfusion System
Historical data
2018 - 2022
Base year
2023
Forecast period
2024 - 2030
Quantitative units
Revenue in USD million
Market segmentation
Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System
Key market players worldwide
Getinge AB ADR, Medtronic PLC, LivaNova PLC, Terumo Corp, Nipro Corp, Fresenius Medical Care AG, Repligen Corp, Spectrum Brands Holdings Inc, Merck KGaA, Xvivo Perfusion AB
Other key industry trends
In terms of revenue, Spain accounted for 2.7% of the global perfusion systems market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Europe, UK perfusion systems market is projected to lead the regional market in terms of revenue in 2030.
UK is the fastest growing regional market in Europe and is projected to reach USD 88.3 million by 2030.
Spain has the highest life expectancy in the EU, averaging 82 years, resulting in a patient population with a higher prevalence of chronic ailments and health challenges associated with old age. Data from the Spanish National Statistics Institute reveals that as of June 2022, over 20% of Spain’s population, totaling 47 million, is aged over 65 years.
In Spain, several people are dealing with long-term health problems that need surgeries, and doctors are using newer & better ways to perform these surgeries. According to the Institut d’Investigació Biomèdica de Bellvitge report of December 2022, nearly 90% of the health issues and deaths in Spain are due to noninfectious diseases, such as heart disease, stroke, COPD, and ARDS.
Moreover, leading companies, such as Terumo Corporation, Medtronic Ibérica S.A.U. (Almacén), and Getinge, play a significant role in this field. Hence, with the growing need for better techniques to treat heart failure, these companies are working on introducing new & improved products and methods for surgeries in Spain.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Perfusion Systems Market Outlook will help companies and investors design strategic landscapes.
Cardiopulmonary Perfusion System was the largest segment with a revenue share of 43.19% in 2023.
Horizon Databook has segmented the Spain perfusion systems market based on cardiopulmonary perfusion system, cell perfusion system, ex-vivo organ perfusion system covering the revenue growth of each sub-segment from 2018 to 2030.
Spain has the highest life expectancy in the EU, averaging 82 years, resulting in a patient population with a higher prevalence of chronic ailments and health challenges associated with old age. Data from the Spanish National Statistics Institute reveals that as of June 2022, over 20% of Spain’s population, totaling 47 million, is aged over 65 years.
In Spain, several people are dealing with long-term health problems that need surgeries, and doctors are using newer & better ways to perform these surgeries. According to the Institut d’Investigació Biomèdica de Bellvitge report of December 2022, nearly 90% of the health issues and deaths in Spain are due to noninfectious diseases, such as heart disease, stroke, COPD, and ARDS.
Moreover, leading companies, such as Terumo Corporation, Medtronic Ibérica S.A.U. (Almacén), and Getinge, play a significant role in this field. Hence, with the growing need for better techniques to treat heart failure, these companies are working on introducing new & improved products and methods for surgeries in Spain.
Spain Perfusion Systems Market Application Outlook (Revenue, USD Million , 2018-2030)
Cardiopulmonary Perfusion System
Cell Perfusion System
Ex-Vivo Organ Perfusion System
Reasons to subscribe to Perfusion Systems Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Perfusion Systems Market Outlook databook
Our clientele includes a mix of Perfusion Systems Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain Perfusion Systems Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Spain Perfusion Systems Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.